{"product_id":"pharmacy-financial-model","title":"Pharmacy Financial Model Template in Excel","description":"\u003cstyle data-fml-style=\"10-safe-dom\"\u003e\n\/* FML Financial Model Product Description v10 — scoped Shopify fragment CSS.\n   Theme owns typography, checkout, product image rendering and Preview. *\/\n.fml-description{\n  --primary:#6067F2;--primary-dark:#2228B0;--soft:#F2F2FF;--xlight:#ECEDFF;\n  --yellow:#FCBD01;--ink:#0F1017;--text:#4C4F62;--muted:#686B80;\n  --line:#E0E1ED;--paper:#FAFAFA;--white:#FFFFFF;\n  box-sizing:border-box;container-type:inline-size;container-name:fml;\n  width:100%;min-width:0;max-width:100%;margin:0;padding:0;\n  font-family:inherit;font-size:17px;line-height:1.7;color:var(--text);background:var(--white)\n}\n.fml-description :where(*):not(.workbook-media,.workbook-media *){box-sizing:border-box}\n.fml-description :where(h2,h3,p,dl,dd,figure):not(.workbook-media *){margin:0;padding:0}\n.fml-description :where(h2,h3):not(.workbook-media *){\n  color:var(--ink);font-weight:650;letter-spacing:-.02em;\n  line-height:1.32;white-space:normal;word-break:normal;overflow-wrap:break-word;hyphens:none\n}\n.fml-description h2{font-size:clamp(26px,3vw,36px)}\n.fml-description h3{font-size:21px}\n.fml-description p{font-size:17px;line-height:1.7;overflow-wrap:break-word;word-break:normal}\n.fml-description strong{font-weight:650}\n.fml-description .container{box-sizing:border-box;width:100%;max-width:1180px;min-width:0;margin-inline:auto;padding-inline:clamp(16px,3%,32px)}\n.fml-description section{box-sizing:border-box;display:block;width:100%;min-width:0;max-width:100%;position:static}\n.fml-description .section{padding-block:58px}\n.fml-description .section.soft-section{background:var(--soft)}\n.fml-description .section.startup-section{background:var(--paper)}\n.fml-description .description-intro{padding-block:34px 16px}\n.fml-description .intro-copy{width:100%;max-width:1050px}\n.fml-description .intro-copy p+p{margin-top:13px}\n.fml-description .section-heading{display:block!important;width:100%;min-width:0;margin:0 0 28px;padding:0}\n.fml-description .section-heading h2{display:block;width:100%;min-width:0;max-width:none;margin:0 0 12px}\n.fml-description .section-heading\u003ep{display:block;width:100%;max-width:910px;margin:0;color:var(--text)}\n.fml-description .eyebrow{display:block;font-size:16px;line-height:1.4;font-weight:650;text-transform:uppercase;letter-spacing:.055em;color:var(--primary-dark);margin-bottom:11px}\n.fml-description .section-copy{display:block;min-width:0;width:100%}\n.fml-description .section-copy p+p{margin-top:12px}\n.fml-description .section-copy h3{margin-bottom:10px}\n.fml-description .section-note{font-size:16px;line-height:1.65;color:var(--muted);margin-top:18px}\n\n\/* Compact numeric facts: independent vertical tracks, never side-by-side value and copy. *\/\n.fml-description .product-facts{\n  display:grid;grid-template-columns:repeat(4,minmax(0,1fr));\n  width:100%;min-width:0;gap:0;border-block:1px solid var(--line);\n  padding-block:23px;margin-top:28px\n}\n.fml-description .product-facts\u003ediv{display:flex;flex-direction:column;align-items:flex-start;min-width:0;padding:0 20px;gap:5px}\n.fml-description .product-facts\u003ediv:first-child{padding-left:0}\n.fml-description .product-facts\u003ediv+div{border-left:1px solid var(--line)}\n.fml-description .product-facts dt{font-size:16px;line-height:1.35;color:var(--muted);white-space:normal}\n.fml-description .product-facts dd{display:flex;flex-direction:column;align-items:flex-start;gap:4px;width:100%;min-width:0;margin:0}\n.fml-description .fact-value{display:block;font-size:clamp(32px,3.5vw,40px);line-height:1.2;font-weight:650;letter-spacing:-.03em;color:var(--primary);white-space:nowrap;font-variant-numeric:tabular-nums}\n.fml-description .fact-detail{display:block;min-width:0;font-size:16px;line-height:1.45;color:var(--text);white-space:normal;word-break:normal}\n\n\/* Flat cards grow with their text; no min-width or fixed height that squeezes headings. *\/\n.fml-description .included-list,.fml-description .use-cases,.fml-description .report-grid{\n  display:grid;grid-template-columns:repeat(3,minmax(0,1fr));gap:20px;width:100%;min-width:0\n}\n.fml-description .included-list article,.fml-description .use-case,.fml-description .report-grid article{\n  min-width:0;max-width:100%;padding:22px 20px;border:1px solid var(--line);\n  background:var(--white);border-radius:10px;box-shadow:none;overflow:visible\n}\n.fml-description .included-list h3,.fml-description .use-case h3,.fml-description .report-grid h3{\n  display:block;width:100%;font-size:20px;margin:0 0 10px;line-height:1.35\n}\n.fml-description .included-list p,.fml-description .use-case p,.fml-description .report-grid p{font-size:16px;line-height:1.65}\n.fml-description .use-case{border-top:3px solid var(--primary)}\n\n\/* The text and its exact worksheet shortcode must share ONE component. *\/\n.fml-description .media-explainer{\n  display:grid;grid-template-columns:minmax(0,1fr) minmax(0,min(39%,420px));\n  width:100%;min-width:0;max-width:100%;gap:clamp(22px,3.5%,48px);\n  align-items:center;margin:34px 0 42px;padding:0;clear:both\n}\n.fml-description .media-explainer[data-fml-side=\"left\"]{grid-template-columns:minmax(0,min(39%,420px)) minmax(0,1fr)}\n.fml-description .media-explainer[data-fml-side=\"left\"]\u003e.section-copy{grid-column:2;grid-row:1}\n.fml-description .media-explainer[data-fml-side=\"left\"]\u003e.workbook-media{grid-column:1;grid-row:1;justify-self:start}\n.fml-description .media-explainer\u003e.section-copy{min-width:0;width:100%;padding:18px clamp(12px,2%,25px)}\n.fml-description .media-explainer\u003e.section-copy h3{font-size:21px;margin-bottom:12px}\n.fml-description .media-explainer\u003e.section-copy p{font-size:17px;line-height:1.7}\n.fml-description .media-explainer\u003e.workbook-media{\n  display:block;min-width:0;width:100%;max-width:420px;margin:0;\n  padding:12px 0 16px;justify-self:end;align-self:center\n}\n.fml-description .workbook-media :where(img,picture){max-width:100%;height:auto}\n\/* Never change the theme's shortcode Preview\/button\/modal descendants. *\/\n\n.fml-description .text-copy{display:block;max-width:1050px;margin:20px 0 26px;min-width:0}\n.fml-description .text-copy p+p{margin-top:13px}\n.fml-description .formula-text{margin:26px 0 32px;padding:18px 20px;border:1px solid var(--line);border-left:4px solid var(--primary);background:var(--white);border-radius:8px}\n.fml-description .formula-text .formula-label{display:block;color:var(--primary-dark);font-size:16px;font-weight:650;margin-bottom:5px}\n.fml-description .formula-text p{color:var(--ink);font-size:17px;line-height:1.65}\n.fml-description .callout{margin:24px 0 30px;padding:18px 22px;border-left:4px solid var(--yellow);background:var(--soft);border-radius:6px}\n.fml-description .callout strong{display:block;font-size:18px;color:var(--primary-dark);margin-bottom:5px}\n.fml-description .callout p{font-size:16px}\n\n\/* Tables are full width and have no hard min-widths. Wide year matrices use years as rows. *\/\n.fml-description .table-shell{display:block;width:100%;min-width:0;max-width:100%;margin:25px 0 32px;overflow:visible;border:1px solid var(--line);border-radius:9px;background:var(--white)}\n.fml-description .data-table{width:100%;min-width:0;max-width:100%;border:0;border-collapse:collapse;table-layout:fixed;font-size:16px;line-height:1.5;font-variant-numeric:tabular-nums}\n.fml-description .data-table caption{caption-side:top;text-align:left;padding:18px 18px 14px;color:var(--ink);font-size:19px;line-height:1.4;font-weight:650}\n.fml-description .data-table :where(th,td){padding:13px 11px;border-bottom:1px solid var(--line);vertical-align:middle;white-space:normal;overflow-wrap:break-word;word-break:normal}\n.fml-description .data-table th:first-child,.fml-description .data-table td:first-child{text-align:left;width:32%}\n.fml-description .data-table :where(td,th:not(:first-child)){text-align:right}\n.fml-description .data-table thead th{font-size:16px;font-weight:650;background:var(--soft);color:var(--primary-dark);line-height:1.4}\n.fml-description .data-table tbody th{font-size:16px;font-weight:600;color:var(--ink)}\n.fml-description .data-table tbody tr:last-child :where(th,td){border-bottom:0}\n.fml-description .data-table tfoot :where(th,td){font-weight:700;color:var(--primary-dark);background:var(--xlight);border-top:2px solid var(--primary);border-bottom:0}\n.fml-description .table-note{margin:0;padding:0 18px 16px;font-size:16px;color:var(--muted);line-height:1.6}\n\n.fml-description .faq-grid{display:grid;grid-template-columns:repeat(2,minmax(0,1fr));gap:28px 34px;min-width:0}\n.fml-description .faq-grid article{min-width:0;padding-top:18px;border-top:1px solid var(--line)}\n.fml-description .faq-grid h3{font-size:19px;margin-bottom:8px}\n.fml-description .faq-grid p{font-size:16px;line-height:1.65}\n\n\/* Container queries use the ACTUAL Shopify description width, not only viewport width. *\/\n@container fml (max-width:1040px){\n  .fml-description .product-facts{grid-template-columns:repeat(2,minmax(0,1fr));row-gap:22px}\n  .fml-description .product-facts\u003ediv:nth-child(odd){padding-left:0;border-left:0}\n  .fml-description .product-facts\u003ediv:nth-child(even){border-left:1px solid var(--line)}\n  .fml-description .product-facts\u003ediv:nth-child(n+3){padding-top:15px;border-top:1px solid var(--line)}\n  .fml-description .included-list,.fml-description .use-cases,.fml-description .report-grid{grid-template-columns:repeat(2,minmax(0,1fr))}\n}\n@container fml (max-width:790px){\n  .fml-description .media-explainer,.fml-description .media-explainer[data-fml-side=\"left\"]{grid-template-columns:minmax(0,1fr);gap:15px;margin:28px 0 38px}\n  .fml-description .media-explainer\u003e.section-copy,.fml-description .media-explainer[data-fml-side=\"left\"]\u003e.section-copy{grid-column:1;grid-row:1;padding:12px 3px 0}\n  .fml-description .media-explainer\u003e.workbook-media,.fml-description .media-explainer[data-fml-side=\"left\"]\u003e.workbook-media{grid-column:1;grid-row:2;justify-self:center;max-width:min(100%,420px);padding:6px 0 20px}\n  .fml-description .section{padding-block:43px}\n  .fml-description .section-heading{margin-bottom:24px}\n}\n@container fml (max-width:620px){\n  .fml-description .included-list,.fml-description .use-cases,.fml-description .report-grid,.fml-description .faq-grid{grid-template-columns:minmax(0,1fr)}\n  .fml-description .product-facts{grid-template-columns:repeat(2,minmax(0,1fr));gap:16px}\n  .fml-description .product-facts\u003ediv{padding:0!important;border:0!important}\n  .fml-description .product-facts\u003ediv:nth-child(n+3){padding-top:16px!important;border-top:1px solid var(--line)!important}\n  .fml-description .product-facts\u003ediv:nth-child(even){padding-left:13px!important;border-left:1px solid var(--line)!important}\n  .fml-description h2{font-size:27px}\n  .fml-description h3{font-size:20px}\n  .fml-description .table-shell{border:0;background:transparent}\n  .fml-description .data-table{display:block;width:100%}\n  .fml-description .data-table caption{display:block;padding:12px 0;font-size:18px}\n  .fml-description .data-table thead{display:none}\n  .fml-description .data-table tbody,.fml-description .data-table tfoot{display:block;width:100%}\n  .fml-description .data-table tbody tr,.fml-description .data-table tfoot tr{display:block;border:1px solid var(--line);background:var(--white);margin-bottom:12px;padding:4px 13px}\n  .fml-description .data-table tbody :where(th,td),.fml-description .data-table tfoot :where(th,td){box-sizing:border-box;display:flex;width:100%;justify-content:space-between;align-items:baseline;gap:16px;text-align:right;padding:9px 0;border:0}\n  .fml-description .data-table tbody th:first-child,.fml-description .data-table tfoot th:first-child{display:block;text-align:left;font-size:17px;border-bottom:1px solid var(--line);width:100%;padding:10px 0}\n  .fml-description .data-table tbody td:before,.fml-description .data-table tfoot td:before{content:attr(data-label);text-align:left;font-weight:550;color:var(--muted);min-width:0;white-space:normal}\n  .fml-description .table-note{padding:4px 0 15px}\n}\n@container fml (max-width:400px){\n  .fml-description .product-facts{grid-template-columns:minmax(0,1fr)}\n  .fml-description .product-facts\u003ediv,.fml-description .product-facts\u003ediv:nth-child(even){border:0!important;padding:0!important}\n  .fml-description .product-facts\u003ediv+div{padding-top:15px!important;border-top:1px solid var(--line)!important}\n  .fml-description .fact-value{font-size:36px}\n  .fml-description .container{padding-inline:14px}\n}\n@media (prefers-reduced-motion:reduce){.fml-description *{transition:none!important;animation:none!important}}\n\n.fml-description .text-link-row{margin:22px 0}.fml-description .text-link{display:inline-block;color:var(--primary-dark);font-weight:650;text-decoration:underline;text-underline-offset:4px;font-size:17px}\n\u003c\/style\u003e\n\u003cdiv class=\"fml-description\" id=\"fml-description\" data-fml-version=\"10-safe-dom\"\u003e\n\u003csection class=\"description-intro\" id=\"fml-description-intro\"\u003e\u003cdiv class=\"container\"\u003e\n\u003cdiv class=\"intro-copy\"\u003e\n\u003cp\u003eThis \u003cstrong\u003ePharmacy Financial Model\u003c\/strong\u003e is an Excel template for planning an independent US community pharmacy from 2026 through 2030. It connects monthly purchasing customers, items sold, realized receipts, merchandise costs, pharmacy staffing, and overhead to projected operating EBITDA.\u003c\/p\u003e\n\u003cp\u003eThe illustrative case is a leased, approximately 1,800-square-foot suburban store with insured and cash prescriptions plus a small retail front end. Prices and reimbursement assumptions are editable estimates, not a representation of any particular payer contract, pharmacy, or local market.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdl class=\"product-facts\" aria-label=\"Financial model facts\"\u003e\n\u003cdiv\u003e\n\u003cdt\u003eForecast\u003c\/dt\u003e\n\u003cdd\u003e\n\u003cstrong class=\"fact-value\"\u003e5\u003c\/strong\u003e\u003cspan class=\"fact-detail\"\u003eannual periods\u003c\/span\u003e\n\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eRevenue streams\u003c\/dt\u003e\n\u003cdd\u003e\n\u003cstrong class=\"fact-value\"\u003e5\u003c\/strong\u003e\u003cspan class=\"fact-detail\"\u003esales categories\u003c\/span\u003e\n\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eUnits per customer\u003c\/dt\u003e\n\u003cdd\u003e\n\u003cstrong class=\"fact-value\"\u003e3\u003c\/strong\u003e\u003cspan class=\"fact-detail\"\u003emonthly planning input\u003c\/span\u003e\n\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003c\/dl\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003csection class=\"section\" id=\"fml-included\"\u003e\u003cdiv class=\"container\"\u003e\n\u003cdiv class=\"section-heading\"\u003e\n\u003cspan class=\"eyebrow\"\u003eWORKBOOK CONTENTS\u003c\/span\u003e\u003ch2\u003eWhat Is Included in the Pharmacy Model?\u003c\/h2\u003e\n\u003cp\u003eThe workbook brings prescription and front-end sales planning together with cost schedules, staffing, startup investment, financing controls, and financial reporting.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"included-list\"\u003e\n\u003carticle\u003e\u003ch3\u003eRevenue and Calc\u003c\/h3\u003e\n\u003cp\u003eEdit purchasing customers, units per customer, sales mix, receipts, and launch timing. Calc converts volume inputs into five monthly revenue streams.\u003c\/p\u003e\u003c\/article\u003e\u003carticle\u003e\u003ch3\u003eCOGS \u0026amp; OPEX and Payroll\u003c\/h3\u003e\n\u003cp\u003eBudget drug acquisition, dispensing materials, processing fees, fixed overhead, and FTE salaries without double-counting payroll.\u003c\/p\u003e\u003c\/article\u003e\u003carticle\u003e\u003ch3\u003eCAPEX, CapTable and Debt\u003c\/h3\u003e\n\u003cp\u003eSchedule opening assets, owner equity, and optional debt. Dashboard controls feed repayment and financing cash-flow schedules.\u003c\/p\u003e\u003c\/article\u003e\u003carticle\u003e\u003ch3\u003eFinancial and decision reports\u003c\/h3\u003e\n\u003cp\u003eInspect the Income Statement, Cash Flow, Balance Sheet, Summary, Scenarios, Returns, Valuation, Sources \u0026amp; Uses, and Checks for reporting and decisions.\u003c\/p\u003e\u003c\/article\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003csection class=\"section soft-section\" id=\"fml-revenue\"\u003e\u003cdiv class=\"container\"\u003e\n\u003cdiv class=\"section-heading\"\u003e\n\u003cspan class=\"eyebrow\"\u003eREVENUE ENGINE\u003c\/span\u003e\u003ch2\u003eHow Does the Model Forecast Pharmacy Sales?\u003c\/h2\u003e\n\u003cp\u003ePurchasing customers multiplied by units per customer form one demand-based sales pool allocated across five priced categories.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"text-copy\"\u003e\n\u003cp\u003eIn 2026, 800 monthly purchasing customers buy an estimated three units each, creating 2,400 units. The monthly customer assumption grows to 1,100, 1,400, 1,700, and 1,900 for 2027–2030.\u003c\/p\u003e\n\u003cp\u003eUnit shares: 66% generic prescriptions at $35, 14% brand at $260, 10% OTC at $14, 6% vitamins at $20, and the residual 4% health supplies at $25. All receipts are estimated per purchased unit.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"media-explainer\" data-fml-topic=\"revenue\" data-fml-side=\"right\"\u003e\n\u003cdiv class=\"section-copy\"\u003e\n\u003ch3\u003eRevenue Forecast\u003c\/h3\u003e\n\u003cp\u003eThe Revenue Forecast applies customer volumes, units per customer, category shares, and realized prices to annual sales. Calc handles monthly timing, including zero revenue before launch and a full launch month.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"workbook-media\"\u003e\n[dynamic_pic2]\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"formula-text\"\u003e\n\u003cspan class=\"formula-label\"\u003eIllustrative 2026 monthly revenue\u003c\/span\u003e\u003cp\u003e800 customers × 3 purchased units × $63.10 weighted receipt = $151,440 per month; 12 months = $1,817,280 in 2026.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"text-copy\"\u003e\n\u003cp\u003eThe $63.10 weighted receipt applies once to the shared unit pool. Modeled receipts are net of payer concessions, and the plan imposes neither a separate capacity limit nor material monthly seasonality.\u003c\/p\u003e\n\u003cp\u003eChange volume, mix, and receipts to test sales sensitivity; the estimates do not represent negotiated pharmacy reimbursement.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003csection class=\"section\" id=\"fml-costs\"\u003e\u003cdiv class=\"container\"\u003e\n\u003cdiv class=\"section-heading\"\u003e\n\u003cspan class=\"eyebrow\"\u003eOPERATING COSTS\u003c\/span\u003e\u003ch2\u003eHow Are Drug Costs and Payroll Calculated?\u003c\/h2\u003e\n\u003cp\u003eDirect acquisition and dispensing costs, other variable expenses, fixed overhead, and base payroll are calculated separately before EBITDA.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"text-copy\"\u003e\n\u003cp\u003eEstimated COGS equals 80.3% for acquisition, 0.3% for bottles and labels, and 0.4% for expiry and shrink: \u003cstrong\u003e81% of revenue\u003c\/strong\u003e in total.\u003c\/p\u003e\n\u003cp\u003eCard processing (0.6%), claims switching (0.2%), and marketing (0.4%) produce \u003cstrong\u003e1.2% variable expenses\u003c\/strong\u003e. Annual fixed expenses are $93,600, including $3,600 monthly rent plus utilities, insurance, compliance, maintenance, and administrative services.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"media-explainer\" data-fml-topic=\"costs\" data-fml-side=\"left\"\u003e\n\u003cdiv class=\"section-copy\"\u003e\n\u003ch3\u003eCOGS and Operating Expenses\u003c\/h3\u003e\n\u003cp\u003eThe COGS and Operating Expenses forecast separates acquisition, revenue-linked operating charges, and fixed overhead. Test how reimbursement and purchasing costs affect margins before payroll.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"workbook-media\"\u003e\n[dynamic_pic10]\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"text-copy\"\u003e\n\u003cp\u003eIn 2026, staffing comprises 1.4 pharmacist FTE at $140,000 per FTE, 2 technician FTE at $43,000, and 0.6 clerk FTE at $34,000. Salaries are not part of COGS.\u003c\/p\u003e\n\u003cp\u003eBase payroll rises from $302,400 in 2026 to $351,500 in 2030 as role-level FTE assumptions change. Each salary is counted once, separate from variable and fixed store costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"media-explainer\" data-fml-topic=\"payroll\" data-fml-side=\"right\"\u003e\n\u003cdiv class=\"section-copy\"\u003e\n\u003ch3\u003ePayroll Forecast by Staff Role\u003c\/h3\u003e\n\u003cp\u003eThe Payroll Forecast calculates personnel costs from FTE and role salaries. The workbook also provides hiring, bonus, and payroll-tax settings, although this example excludes employer taxes and benefits.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"workbook-media\"\u003e\n[dynamic_pic8]\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003caside class=\"callout\"\u003e\u003cstrong\u003eScope of the expense example\u003c\/strong\u003e\u003cp\u003eThe supplied case excludes employer taxes, benefits, and personal taxes; validate these and local pharmacy costs separately.\u003c\/p\u003e\u003c\/aside\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003csection class=\"section startup-section\" id=\"fml-startup\"\u003e\u003cdiv class=\"container\"\u003e\n\u003cdiv class=\"section-heading\"\u003e\n\u003cspan class=\"eyebrow\"\u003eSTARTUP AND FUNDING\u003c\/span\u003e\u003ch2\u003eWhat Startup Investment Does the Model Track?\u003c\/h2\u003e\n\u003cp\u003eOpening equipment and improvements, prelaunch cash costs, working capital, and initial owner funding are planned outside recurring operating EBITDA.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"text-copy\"\u003e\n\u003cp\u003eFour quantified opening assets total \u003cstrong\u003e$116,500\u003c\/strong\u003e: $70,000 in improvements, $22,000 in fixtures, $18,000 in computer and dispensing hardware, and $6,500 in refrigeration. Safes, cameras, and signage are additional assets without specified amounts.\u003c\/p\u003e\n\u003cp\u003ePrelaunch permits, deposits, software setup, training, wages, and launch marketing are separate opening cash uses, not annual operating expenses or EBITDA deductions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"media-explainer\" data-fml-topic=\"capex\" data-fml-side=\"right\"\u003e\n\u003cdiv class=\"section-copy\"\u003e\n\u003ch3\u003eCapital Expenditure Plan\u003c\/h3\u003e\n\u003cp\u003eThe Capital Expenditure Plan schedules pharmacy equipment and improvements by date and depreciability. It distinguishes asset investment cash outlays from ongoing operating costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"workbook-media\"\u003e\n[dynamic_pic9]\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"text-copy\"\u003e\n\u003cp\u003eEstimated owner funding is \u003cstrong\u003e$757,890\u003c\/strong\u003e, covering opening assets, prelaunch cash, opening net working capital, and a three-month operating reserve. The reserve is policy, not verified peak-cash sufficiency.\u003c\/p\u003e\n\u003cp\u003eWorking-capital inputs assume 12 receivables days, 15 payables days, and 30 inventory days. They change projected cash timing without automatically changing EBITDA.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"media-explainer\" data-fml-topic=\"funding\" data-fml-side=\"left\"\u003e\n\u003cdiv class=\"section-copy\"\u003e\n\u003ch3\u003eSources and Uses of Funds\u003c\/h3\u003e\n\u003cp\u003eSources and Uses of Funds reconciles equity and optional debt with operating payments, investment, and retained cash. It helps compare the revised opening investment against planned funding.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"workbook-media\"\u003e\n[dynamic_pic3]\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003csection class=\"section soft-section\" id=\"fml-forecast\"\u003e\u003cdiv class=\"container\"\u003e\n\u003cdiv class=\"section-heading\"\u003e\n\u003cspan class=\"eyebrow\"\u003eFIVE-YEAR PROJECTIONS\u003c\/span\u003e\u003ch2\u003eWhat Does the Example Pharmacy Forecast Show?\u003c\/h2\u003e\n\u003cp\u003eThe documented illustrative Base operating case shows rising annual revenue and EBITDA as monthly purchasing-customer assumptions increase.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"table-shell\"\u003e\n\u003ctable class=\"data-table\"\u003e\n\u003ccaption\u003eIllustrative pharmacy operating forecast, USD\u003c\/caption\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth scope=\"col\"\u003eYear\u003c\/th\u003e\n\u003cth scope=\"col\"\u003eRevenue\u003c\/th\u003e\n\u003cth scope=\"col\"\u003eOperating Expenses\u003c\/th\u003e\n\u003cth scope=\"col\"\u003eEBITDA\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth scope=\"row\"\u003e2026\u003c\/th\u003e\n\u003ctd data-label=\"Revenue\"\u003e$1,817,280\u003c\/td\u003e\n\u003ctd data-label=\"Operating Expenses\"\u003e$1,889,804\u003c\/td\u003e\n\u003ctd data-label=\"EBITDA\"\u003e-$72,524\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth scope=\"row\"\u003e2027\u003c\/th\u003e\n\u003ctd data-label=\"Revenue\"\u003e$2,498,760\u003c\/td\u003e\n\u003ctd data-label=\"Operating Expenses\"\u003e$2,455,081\u003c\/td\u003e\n\u003ctd data-label=\"EBITDA\"\u003e$43,679\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth scope=\"row\"\u003e2028\u003c\/th\u003e\n\u003ctd data-label=\"Revenue\"\u003e$3,180,240\u003c\/td\u003e\n\u003ctd data-label=\"Operating Expenses\"\u003e$3,039,557\u003c\/td\u003e\n\u003ctd data-label=\"EBITDA\"\u003e$140,683\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth scope=\"row\"\u003e2029\u003c\/th\u003e\n\u003ctd data-label=\"Revenue\"\u003e$3,861,720\u003c\/td\u003e\n\u003ctd data-label=\"Operating Expenses\"\u003e$3,611,734\u003c\/td\u003e\n\u003ctd data-label=\"EBITDA\"\u003e$249,986\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth scope=\"row\"\u003e2030\u003c\/th\u003e\n\u003ctd data-label=\"Revenue\"\u003e$4,316,040\u003c\/td\u003e\n\u003ctd data-label=\"Operating Expenses\"\u003e$3,992,885\u003c\/td\u003e\n\u003ctd data-label=\"EBITDA\"\u003e$323,155\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp class=\"table-note\"\u003eIllustrative projections, rounded to whole dollars. Operating expenses include COGS, variable, fixed, and payroll costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"text-copy\"\u003e\n\u003cp\u003eThe example moves from \u003cstrong\u003enegative $72,524 EBITDA in 2026\u003c\/strong\u003e to \u003cstrong\u003e$323,155 in 2030\u003c\/strong\u003e, as annual revenue reaches $4,316,040 under the selected assumptions.\u003c\/p\u003e\n\u003cp\u003eEBITDA is neither net profit nor cash. The Income Statement, Cash Flow, and Balance Sheet model additional financial measures, but the supplied case establishes no net income or closing cash figures.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"media-explainer\" data-fml-topic=\"cashflow\" data-fml-side=\"right\"\u003e\n\u003cdiv class=\"section-copy\"\u003e\n\u003ch3\u003eCash Flow Forecast\u003c\/h3\u003e\n\u003cp\u003eThe Cash Flow Forecast separates operating cash, purchases, equity and debt movements, and opening-to-closing balances. Consult it for liquidity rather than treating EBITDA as available cash.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"workbook-media\"\u003e\n[dynamic_pic12]\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003caside class=\"callout\"\u003e\u003cstrong\u003eForecast, not industry actuals\u003c\/strong\u003e\u003cp\u003eThese are illustrative estimates, not observed pharmacy results. Validate supplier terms, payer contracts, wages, taxes, and funding.\u003c\/p\u003e\u003c\/aside\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003csection class=\"section\" id=\"fml-returns\"\u003e\u003cdiv class=\"container\"\u003e\n\u003cdiv class=\"section-heading\"\u003e\n\u003cspan class=\"eyebrow\"\u003eDECISION ANALYSIS\u003c\/span\u003e\u003ch2\u003eHow Can You Evaluate Break-Even and Payback?\u003c\/h2\u003e\n\u003cp\u003eThe workbook separates operational sales thresholds from cash recovery, financing requirements, and returns on invested capital.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"text-copy\"\u003e\n\u003cp\u003eReturns distinguishes sales break-even, cash break-even, investment payback, and annual ROIC. These address cost coverage, cash recovery timing, invested capital recovery, and capital productivity.\u003c\/p\u003e\n\u003cp\u003eThe supplied case establishes no payback month, ROIC, IRR, or discounted value; none can be inferred solely from EBITDA.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"media-explainer\" data-fml-topic=\"returns\" data-fml-side=\"left\"\u003e\n\u003cdiv class=\"section-copy\"\u003e\n\u003ch3\u003eBreak-Even, Payback and ROIC\u003c\/h3\u003e\n\u003cp\u003eThe Returns report analyzes operating sales thresholds, project free cash flow, payback, and annual ROIC. Enter pharmacy-specific investments and cash assumptions before using its outputs for decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"workbook-media\"\u003e\n[dynamic_pic4]\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"text-copy\"\u003e\u003cp\u003eDashboard Scenario Controls apply Low, Base, and High multipliers to revenue and all four cost layers. Scenarios compares operating margins and EBITDA; Debt and Valuation support separate financing decisions.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003csection class=\"section\" id=\"fml-fit\"\u003e\u003cdiv class=\"container\"\u003e\n\u003cdiv class=\"section-heading\"\u003e\n\u003cspan class=\"eyebrow\"\u003ePRACTICAL USE\u003c\/span\u003e\u003ch2\u003eWho Can Use This Pharmacy Financial Template?\u003c\/h2\u003e\n\u003cp\u003eDesigned for independent pharmacy operators, prospective buyers, and advisers testing conventional retail dispensing economics.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"text-copy\"\u003e\n\u003cp\u003eTest prescription mix, customer capture, FTE coverage, and startup funding. Specialty dispensing, compounding, mail order, clinical services, delivery sales, and franchise fees are outside this case.\u003c\/p\u003e\n\u003cp\u003eReplace estimates with payer contracts, supplier quotes, lease terms, wage requirements, licensing costs, and opening inventory before relying on the projections.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003csection class=\"section\" id=\"fml-faq\"\u003e\u003cdiv class=\"container\"\u003e\n\u003cdiv class=\"section-heading\"\u003e\n\u003cspan class=\"eyebrow\"\u003eFREQUENTLY ASKED QUESTIONS\u003c\/span\u003e\u003ch2\u003ePharmacy Financial Model FAQs\u003c\/h2\u003e\n\u003cp\u003eThese answers clarify how to adapt the forecast, what the illustrative figures represent, and which reports answer common planning questions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"faq-grid\"\u003e\n\u003carticle\u003e\u003ch3\u003eCan I change prescription and front-end sales assumptions?\u003c\/h3\u003e\n\u003cp\u003eYes. Edit purchasing customers, purchased units per customer, generic and brand shares, retail category shares, and realized unit receipts in the Revenue inputs.\u003c\/p\u003e\u003c\/article\u003e\u003carticle\u003e\u003ch3\u003eDoes the forecast model payer reimbursement contracts?\u003c\/h3\u003e\n\u003cp\u003eIt uses estimated realized per-unit receipts net of concessions, not an independently verified insurer, PBM, or Medicaid reimbursement contract.\u003c\/p\u003e\u003c\/article\u003e\u003carticle\u003e\u003ch3\u003eAre pharmacist and technician salaries included?\u003c\/h3\u003e\n\u003cp\u003eYes. Base pay is planned in Payroll by full-time-equivalent role, and the illustrated costs do not count those salaries again in COGS or fixed overhead.\u003c\/p\u003e\u003c\/article\u003e\u003carticle\u003e\u003ch3\u003eAre startup purchases part of EBITDA?\u003c\/h3\u003e\n\u003cp\u003eNo. Opening assets and prelaunch cash uses are tracked separately; depreciation and investment cash flows appear in their corresponding financial reports.\u003c\/p\u003e\u003c\/article\u003e\u003carticle\u003e\u003ch3\u003eCan I analyze cash needs or debt financing?\u003c\/h3\u003e\n\u003cp\u003eYes. Cash Flow, Sources \u0026amp; Uses, and Debt schedules support liquidity and financing analysis, but the supplied reserve is not a tested peak-cash sufficiency result.\u003c\/p\u003e\u003c\/article\u003e\u003carticle\u003e\u003ch3\u003eDoes positive EBITDA mean the investment pays back?\u003c\/h3\u003e\n\u003cp\u003eNo. Sales break-even, cash break-even, project payback, and ROIC require distinct calculations in Returns and cannot be inferred from EBITDA alone.\u003c\/p\u003e\u003c\/article\u003e\u003carticle\u003e\u003ch3\u003eAre the five-year figures pharmacy industry averages?\u003c\/h3\u003e\n\u003cp\u003eNo. They are illustrative 2026–2030 projections based on estimated assumptions for one independent suburban US pharmacy, not observed industry results.\u003c\/p\u003e\u003c\/article\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\n\u003c\/div\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":48218037944563,"sku":"pharmacy-financial-model","price":109.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/pharmacy-financial-model-headimage-financialmodelslab_e78036f8-eebe-4013-bef0-0062399606b4.webp?v=1765297435","url":"https:\/\/finmodelslab.myshopify.com\/products\/pharmacy-financial-model","provider":"Financial Models Lab Templates","version":"1.0","type":"link"}